Detail of the clinical trial

Title of the trial A phase II, multi-centre study investiaging the safety and efficacy of ofatumumab and bendamustine combination in patients with untreated or relapsed chronic lymphocytic leukaemia (CLL)
EudraCT number 2011-005178-43
Protocol number OMB115991
Sponsor GlaxoSmithKline Research & Development Limited, UK
Indications Hemato-oncology
Diagnosis relapsed chronic lymphocytic leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2011
Date of approval by Institute (SÚKL) 18.1.2012
Date of approval by EC 8.2.2012
Date of initiation CT in ČR 28.3.2012
Date of ending CT in ČR 11.2.2016
Notice
Sites VFN, I. interní klinika, Praha
FN Olomouc, Hematoonkologická klinika
FN Hradec Králové, 2. interní klinika odd. klinické hematologie
FN Brno, IHOK

‹‹ Back to list